Half year results to end September 2013 – the fund, which is realising its investments and returning cash to shareholders, had 14.95p of cash per share at the end of September (out of a total NAV of 18.64p). IMAC is planning a distribution of 10p per share payable by 10 January 2014. IMAC still owns […]
Greencoat has raised an additional £83m from investors and will issue 80.975m shares at 102.5p using the money to pay down part of its debt – to leave £50m outstanding.
RSE will contribute $100m towards $300m being committed by Riverstone companies towards Eagle Energy Exploration. Eagle’s focus is on oil & gas exploration and production in mid US (exploiting the Mississippi Lime trend).
GCP has lent £14.5m to finance the construction of a 10.3 MWe wood fuelled biomass power plant in Tynsley, Birmingham. The 17 year loan will yield 9.1% pa.
JAI has released its results for the year ended 30 September 2013. In NAV terms the company returned 6.4%, beating its benchmark which returned 5.1%. The discount narrowed so the share price return was 7.2%. The Board are pleased that JAI beat its benchmark over the year but say they are determined that this should only be […]
Results for the six months ended 30 September 2013. NAV falls to 40.7p from 55.3p in part because of an 11% adverse shift in the sterling / rouble exchange rate but also because the valuations of AURR’s remaining investments has been reduced. AURR’s valuation of Unistream fell to £10.7m from £12m – growth has been lower […]
Praetorian Resources six months to the end of September 2013 saw the NAV fall from 32p to 21p as junior resources companies remained out of favour. The Board is asking for investors’ patience and hopes to raise more money for the fund to take advantage of what it thinks are the recovery prospects for its […]
DCG Iris has released a statement about the winter storm known as Xaver or Bodil. DCG believe the impact of the storm may have been less than that of Christian, the previous winter storm that struck Europe. Christian hit when the trees were in full leaf and caused many to topple while Xaver’s main impact […]
MedicX plans to buy a primary care medical centre in Buckley, Flintshire for £7.6m when it is complete in February 2015
Over the year to the end of October BRNA returned 17.1% in NAV terms and 16.5% in share price terms vs. a return for the Russell 1000 Value Index of 27.4% – underperformance relative to the index is attributed by the Board to the outperformance of “lower quality stocks” that BRNA does not hold.